Taste is one of the most important parameters governing patient compliance with oral solid dosage forms, especially for specialized populations, such as pediatrics. Many active ingredients in today’s development pipelines have bitter taste, coupled with other formulation needs such as modifying release rates and/or improving solubility. Effective taste masking can translate into better compliance and contribute to the overall therapeutic value for patients.
Current taste masking approaches, with emphasis on two growing technology options – lipid multiparticulate (LMP) technology and osmotic bursting technology—will be reviewed.
Representative case studies will be presented and time reserved for Q&A.
Speakers for the webinar are:
See the webinar here: